Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.

[1]  H. M. Oberholzer,et al.  A review of immunomodulators with reference to Canova. , 2009, Homeopathy : the journal of the Faculty of Homeopathy.

[2]  A. Khayat,et al.  Lymphocyte proliferation stimulated by activated human macrophages treated with Canova. , 2009, Homeopathy : the journal of the Faculty of Homeopathy.

[3]  M. Gomes,et al.  Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole , 2008, Homeopathy.

[4]  Ronald Anderson,et al.  Differentiation of Human Monocytes in Vitro Following Exposure to Canova in the Absence of Cytokines , 2008, Ultrastructural pathology.

[5]  K. Senior.  Chagas disease: moving towards global elimination. , 2007, The Lancet. Infectious diseases.

[6]  T. Svidzinski,et al.  Biochemical responses in mice experimentally infected with Paracoccidioides brasiliensis and treated with Canova , 2006 .

[7]  J. Gabardo,et al.  Activation of bone marrow cells treated with Canova in vitro , 2006, Cell biology international.

[8]  T. Svidzinski,et al.  In vivo and in vitro effects of the Canova medicine on experimental infection with Paracoccidioides brasiliensis in mice , 2006 .

[9]  Lyris M F Godoy,et al.  Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication. , 2006, Micron.

[10]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.

[11]  M. Lonardoni,et al.  Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. , 2005, The Journal of infection.

[12]  O. Tapia,et al.  The chemotherapy of chagas' disease: an overview. , 2005, Mini reviews in medicinal chemistry.

[13]  T. Araújo-Jorge,et al.  Benznidazole Therapy in Trypanosoma cruzi-Infected Mice Blocks Thymic Involution and Apoptosis of CD4+CD8+ Double-Positive Thymocytes , 2005, Antimicrobial Agents and Chemotherapy.

[14]  E. Stroparo.  Pacientes HIV/AIDS+ tratados com o medicamento homeopático Canova : estudo prospectivo observacional em índices laboratoriais, clínicos e de qualidade de vida , 2005 .

[15]  Raffaello Popa Di Bernardi.  Recuperaçao de pacientes com HIV/AIDS+ em Botswana, África, com o uso do medicamento homeopático Canova , 2005 .

[16]  J. Gabardo,et al.  Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication , 2005, Homeopathy.

[17]  I. Cabral,et al.  The anticancer homeopathic composite "Canova Method" is not genotoxic for human lymphocytes in vitro. , 2003, Genetics and molecular research : GMR.

[18]  I. Sayeed,et al.  Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. , 2003, International immunopharmacology.

[19]  T. Araújo-Jorge,et al.  Benznidazole Treatment following Acute Trypanosoma cruzi Infection Triggers CD8+ T-Cell Expansion and Promotes Resistance to Reinfection , 2002, Antimicrobial Agents and Chemotherapy.

[20]  R. Gazzinelli,et al.  Experimental chemotherapy against Trypanosoma cruzi infection: essential role of endogenous interferon-gamma in mediating parasitologic cure. , 2002, The Journal of infectious diseases.

[21]  M. DaRochaPiemonte,et al.  Analysis of IL-2, IFN-gamma and TNF-alpha production, alpha5 beta1 integrins and actin filaments distribution in peritoneal mouse macrophages treated with homeopathic medicament. , 2002 .

[22]  J. Coura,et al.  A critical review on Chagas disease chemotherapy. , 2002 .

[23]  O. Bottasso,et al.  Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats , 2001, Parasitology Research.

[24]  R. Docampo,et al.  Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites. , 2001, Current drug targets. Infectious disorders.

[25]  T. Araújo-Jorge,et al.  Enzymatic markers of heart lesion in mice infected with Trypanosoma cruzi and submitted to benznidazole chemotherapy , 2000, Parasitology Research.

[26]  Riarte,et al.  Soluble platelet selectin (sP‐selectin) and soluble vascular cell adhesion molecule‐1 (sVCAM‐1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease , 1999, Clinical and experimental immunology.

[27]  K. Sainis,et al.  Studies on the immunomodulatory effects of Boerhaavia diffusa alkaloidal fraction. , 1999, Journal of ethnopharmacology.

[28]  J. Ramirez,et al.  Myocardial parasite persistence in chronic chagasic patients. , 1999, The American journal of tropical medicine and hygiene.

[29]  A. Stoppani.  [The chemotherapy of Chagas disease]. , 1999, Medicina.

[30]  R. Gazzinelli,et al.  Interleukin-12 Enhances In Vivo Parasiticidal Effect of Benznidazole during Acute Experimental Infection with a Naturally Drug-Resistant Strain of Trypanosoma cruzi , 1998, Antimicrobial Agents and Chemotherapy.

[31]  R. Gazzinelli,et al.  Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. , 1998, Molecular and biochemical parasitology.

[32]  S. D. Pena,et al.  Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. , 1998, Experimental parasitology.

[33]  R. Nelson,et al.  Immunopharmacology: immunomodulation and immunotherapy. , 1997, JAMA.

[34]  V. Yardley,et al.  Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines. , 1997, Journal of medicinal chemistry.

[35]  Z. Andrade,et al.  Parasitism of adipocytes by Trypanosoma cruzi. , 1995, Memorias do Instituto Oswaldo Cruz.

[36]  F. Cunha,et al.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro , 1994, Infection and immunity.

[37]  A. Sher,et al.  The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.

[38]  A. Fairlamb,et al.  Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases , 1992, Parasitology.

[39]  R. Millikan,et al.  Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. , 1991, Molecular and biochemical parasitology.

[40]  A. Coutinho,et al.  Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. , 1991, International Immunology.

[41]  R. Tarleton.  The role of T-cell subpopulations in experimental Chagas' disease. , 1991, Research in immunology.

[42]  R. Tarleton.  Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. , 1990, Journal of immunology.

[43]  L. Filardi,et al.  Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  J. Wietzerbin,et al.  Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo. , 1987, Annales de l'Institut Pasteur. Immunology.

[45]  A. Zlotnik,et al.  Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi , 1985, Infection and immunity.

[46]  G. Targett.  Chemotherapy and the immune response in parasitic infections , 1985, Parasitology.

[47]  S. G. Andrade,et al.  [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi]. , 1977, Revista do Instituto de Medicina Tropical de São Paulo.

[48]  E. Camargo.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA. , 1964, Revista do Instituto de Medicina Tropical de Sao Paulo.

[49]  Z. Brener.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.